Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, ...

Eli Lilly and Company (NYSE: LLY) announced results from the long-term extension (LTE) of the Phase 3 TRAILBLAZER-ALZ 2 study ...

Cognition Therapeutics’ therapy showed up to a 129% slowing of cognitive decline in mild Alzheimer’s disease patients.

This groundbreaking study demonstrates that copper in the brain-not just in the blood-may help preserve cognitive function. As a vital trace element, copper could play a role in preventing Alzheimer's ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

This Research Topic aims to explore how cellular metabolites (intermediates or end-products of metabolic processes) influence neuronal activity in both ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

For older adults who may otherwise be food-insecure, participating in food assistance benefits may be associated with a ...

The idea that herpes infections trigger or contribute to Alzheimer's disease has been gaining favor among some scientists, ...

Researchers have found a way to rejuvenate the glycocalyx, the “sugar shield” that bolsters the blood-brain barrier. Exciting ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

Walking and other lifestyle habits may slow cognitive decline in APOE ε4 carriers — possibly offering greater benefits than ...